Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma × Blood Specimen Collection × Clear all

Phase

Phase NA 6 Phase 1 2 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Breast Neoplasms 4 Colorectal Neoplasms 3 Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma, Myeloid 1 Sarcoma 1 Rhabdoid Tumor 1 Pyloric Stenosis, Hypertrophic 1 Prostatic Neoplasms 1 Polycythemia Vera 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 High Grade Neuroendocrine Neoplasms 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Glioblastoma 1 Cytomegalovirus Infections 1 Colonic Neoplasms 1

Interventions

Cyclophosphamide 203 Rituximab 185 Etoposide 117 Filgrastim 96 Vincristine 88 Doxorubicin 84 Cytarabine 77 Radiotherapy 70 Prednisone 69 Methotrexate 64 fludarabine phosphate 63 Peripheral Blood Stem Cell Transplantation 62 Melphalan 62 Busulfan 50 Carmustine 40 Dexamethasone 39 fludarabine 37 Tacrolimus 36 Mycophenolic Acid 36 Granulocyte Colony-Stimulating Factor 35 Antilymphocyte Serum 34 Ifosfamide 33 Whole-Body Irradiation 29 Bortezomib 28 sargramostim 26 Cyclosporine 26 Methylprednisolone 25 Gemcitabine 25 Bendamustine Hydrochloride 24 Cisplatin 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02260414 2017-05-11

METRO B

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Completed

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡